Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats; Phytomedicine; Vol. 23, iss. 7

Bibliografiske detaljer
Parent link:Phytomedicine
Vol. 23, iss. 7.— 2016.— [P. 784–792]
Institution som forfatter: Национальный исследовательский Томский политехнический университет Управление проректора по научной работе и инновациям Центр RASA в Томске Лаборатория изучения механизмов нейропротекции
Andre forfattere: Atochin D. N. Dmitry Nikolaevich, Chernysheva G. A., Smolyakova V. I., Osipenko A. N., Logvinov S. V. S. V., Zhdankina A. A., Sysolyatin S. V., Kryukov Yu. A., Anfinogenova Ya. J. Yana Jonovna, Plotnikova T. M., Plotnikov M. B.
Summary:Title screen
Background. Salidroside is a biologically active compound derived from Rhodiola rosea L. Studies showed that salidroside after i.v. injection is extensively metabolized to p-tyrosol and only trace amounts of salidroside are found in the brain tissue.Objective. The aim of the study was to investigate the neuroprotective effects of p-tyrosol in the global cerebral ischemia-reperfusion (GCI) model.Study design. A total of 103 Wistar rats were assigned to groups of sham-operated (n = 10), control (n = 42), p-tyrosol-treated (n = 36), and pentoxifylline-treated (n = 15) animals. The rats of control, p-tyrosol-treated, and pentoxifylline-treated groups received intravenously 0.9% NaCl solution, 2% solution of p-tyrosol in doses of 5 mg/kg, 10 mg/kg, and 20 mg/kg, and pentoxifylline in a dose of 100 mg/kg, respectively, daily for 5 days. Rats were examined at days 1, 3, and 5 after GCI. After evaluation of neurological deficit, animals were euthanized for morphological and biochemical characterization.
Режим доступа: по договору с организацией-держателем ресурса
Sprog:engelsk
Udgivet: 2016
Fag:
Online adgang:http://dx.doi.org/10.1016/j.phymed.2016.03.015
Format: MixedMaterials Electronisk Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=651337

MARC

LEADER 00000naa0a2200000 4500
001 651337
005 20250320092741.0
035 |a (RuTPU)RU\TPU\network\16586 
035 |a RU\TPU\network\16462 
090 |a 651337 
100 |a 20161109d2016 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats  |f D. N. Atochin [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: p. 791-792 (36 tit.)] 
330 |a Background. Salidroside is a biologically active compound derived from Rhodiola rosea L. Studies showed that salidroside after i.v. injection is extensively metabolized to p-tyrosol and only trace amounts of salidroside are found in the brain tissue.Objective. The aim of the study was to investigate the neuroprotective effects of p-tyrosol in the global cerebral ischemia-reperfusion (GCI) model.Study design. A total of 103 Wistar rats were assigned to groups of sham-operated (n = 10), control (n = 42), p-tyrosol-treated (n = 36), and pentoxifylline-treated (n = 15) animals. The rats of control, p-tyrosol-treated, and pentoxifylline-treated groups received intravenously 0.9% NaCl solution, 2% solution of p-tyrosol in doses of 5 mg/kg, 10 mg/kg, and 20 mg/kg, and pentoxifylline in a dose of 100 mg/kg, respectively, daily for 5 days. Rats were examined at days 1, 3, and 5 after GCI. After evaluation of neurological deficit, animals were euthanized for morphological and biochemical characterization. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Phytomedicine 
463 |t Vol. 23, iss. 7  |v [P. 784–792]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
701 1 |a Atochin  |b D. N.  |c neuroscientist  |c The Head of the Laboratory of Tomsk Polytechnic University  |f 1960-  |g Dmitry Nikolaevich  |3 (RuTPU)RU\TPU\pers\37514  |9 20383 
701 1 |a Chernysheva  |b G. A. 
701 1 |a Smolyakova  |b V. I. 
701 1 |a Osipenko  |b A. N. 
701 1 |a Logvinov S. V.  |b S. V. 
701 1 |a Zhdankina  |b A. A. 
701 1 |a Sysolyatin  |b S. V. 
701 1 |a Kryukov  |b Yu. A. 
701 1 |a Anfinogenova  |b Ya. J.  |c Linguist  |c Lecturer of Tomsk Polytechnic University, Doctor of medical sciences  |f 1970-  |g Yana Jonovna  |3 (RuTPU)RU\TPU\pers\33592  |9 17250 
701 1 |a Plotnikova  |b T. M. 
701 1 |a Plotnikov  |b M. B. 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Управление проректора по научной работе и инновациям  |b Центр RASA в Томске  |b Лаборатория изучения механизмов нейропротекции  |3 (RuTPU)RU\TPU\col\21815  |9 28136 
801 2 |a RU  |b 63413507  |c 20161109  |g RCR 
856 4 |u http://dx.doi.org/10.1016/j.phymed.2016.03.015 
942 |c CF